Deciphera Pharmaceuticals (DCPH) Misses Q3 EPS by 9c

Deciphera Pharmaceuticals (NASDAQ: DCPH) reported Q3 EPS of ($1.37), $0.09 worse than the analyst estimate of ($1.28). Revenue for the quarter came in at $23.2 million versus the consensus estimate of $23.36 million.

For earnings history and earnings-related data on Deciphera Pharmaceuticals (DCPH) click here.

You May Also Be Interested In

• Bristol-Myers Squibb (BMY) stock slips despite earnings beat
• Old Republic (ORI) Tops Q1 EPS by 2c
• Opera Limited (OPRA) Misses Q1 EPS by 5c, provides guidance